Searched for
ARENA PHARMACEUTICALS
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...- Who was David Wilcock? The latest death in a growing ‘missing US scientists’ narrative tied to UFO claimsUFO disclosure advocate David Wilcock died by suicide on April 20, 2026, following a mental health crisis response. His death occurred amid...
- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...
- Pfizer will spend $43 billion to acquire Seagen"Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combinin...
- Pfizer buys Seagen for $43B, boosts access to cancer drugsThe deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...
- India targeting global arena with high value pharma, med-tech products, says MandaviyaMandaviya said the union government is promoting an enabling ecosystem for innovation in the pharma-medtech sector to become a leader in dr...
- Moscow says India may replace West in Russian pharmaceuticals market"The withdrawal of many Western companies from the Russian market and those niches that have been vacated may actually be occupied by India...
- Share market update: 55 stocks hit 52-week highs on NSEOverall, 40 shares were trading in green in Nifty50 index, while 9 were trading in red.
- Share market update: Over 50 stocks defy positive market mood, hit 52-week lows on NSEEquity market was in the positive terrain on healthy buying by investors.
- Stock market update: Over 10 stocks hit 52-week highs on NSEEquity markets were in the green as investors' optimism level was lifted by firm IIP data.
- Pharma exports up 9.7 per cent, 33 per cent growth in US markets in FY16Generic drugs form the largest segment, with 75 per cent of market share (in terms of revenues), of the Indian pharmaceutical sector.
- Suven Life Sciences granted patents for neurodegenerative drugWith these new patents, Suven has a total of 19 granted patents from Australia, 14 from Japan and 15 from Hong Kong.
- Suven Life Sciences granted patents for neurodegenerative drugVenkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena.
- Suven Life Sciences gets 3 patents in Canada, China, IndiaSuven Life has received three product patents in Canada, China and India for its new chemical entities for treatment of neurodegenerative d...
- Lambda Therapeutic holds symposium on clinical trial innovationsLambda Therapeutic Research concluded two day symposium on "Innovation in Clinical Trials" at Ahmedabad. Delegates across pharmaceutical an...
- Glenmark most promising in pharma pack: Networth Stock BrokingGlenmark is one stock that we particularly like because it has the FDA filing which it has gone ahead.
- Midcap pharma, a robust story: Gajendra NagpalWhen broader markets or the stocks which are index based are reasonably priced and the sentiment remains buoyant, there is a tendency for s...
- Lupin, Cadila, Strides Arcolab, Ipca Laboratories and Biocon are good bets: Ashit SuriIn pharma space, big players like Lupin and Cadila have been very consistent in the performances.
- Suven Life Sciences, US co enter deal on pre-clinical researchSuven Life Sciences has entered into an agreement with Eli Lilly to collaborate on the pre-clinical research of molecules in the therapeuti...
- Two Indians among world's top 25 consultantsN Chandrasekaran of the country's largest IT firm Tata Consultancy Services and global management consultancy Bain & Company's Ashish Singh...
Load More
